Privia Health Group (PRVA) EBITDA (2020 - 2026)
Privia Health Group (PRVA) EBITDA from Mar 31, 2020 to Mar 31, 2026. The TTM Privia Health Group (PRVA) EBITDA is $48M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Privia Health Group (PRVA) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +66.13% |
| 3 Years TTM | +129.86% |
| 5 Years TTM | +10.68% |
| All Time TTM | +10.68% |
Annual EBITDA change of Privia Health Group (PRVA)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $11M | -75.76% |
| 2025 | $44M | +82.02% |
| 2024 | $24M | -10.78% |
| 2023 | $27M | -286.80% |
| 2022 | -$15M | -93.23% |
| 2021 | -$215M | -889.75% |
| 2020 | $27M | +55.63% |
| 2019 | $17M | N/A |
Comparison Privia Health Group (PRVA) five years EBITDA CAGR with competitors
Privia Health Group (PRVA) five years EBITDA CAGR is 10.68%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| OPRX | OptimizeRx Corp | 77.72% | +628.05% |
| CCLD | CareCloud Inc | 73.90% | +592.22% |
| CCLDO | CareCloud Inc | 73.90% | +592.22% |
| SY | So-Young International Inc | 39.98% | +274.48% |
| DOCS | Doximity Inc - Class A | 32.10% | +200.68% |
| HQY | Healthequity Inc | 28.20% | +164.17% |
| VEEV | Veeva Systems Inc - Class A | 23.79% | +122.85% |
| HCAT | Health Catalyst Inc | 20.13% | +88.61% |
| SDGR | Schrodinger Inc | 18.03% | +68.91% |
| EVH | Evolent Health Inc - Class A | 9.64% | -9.72% |
| SOPH | SOPHiA Genetics SA | 9.32% | -12.71% |
| HSTM | Healthstream Inc | 9.04% | -15.34% |
| SLP | Simulations Plus Inc | 2.64% | -75.27% |
| OMCL | Omnicell Inc | 0.63% | -94.12% |
| DRIO | DarioHealth Corp | 0.22% | -97.95% |